Scientific Communications Group is a full spectrum, scientific communications firm focusing on educating healthcare professionals who come in contact with rare disease patients. Our aim is to effectively communicate the science behind rare diseases. Our team has over 25 years of experience in the healthcare industry and has expertise in the dissemination of scientific content by combining our scientific knowledge with our clients strategic goals and objectives.
Our teams are made up of seasoned professionals that have medical, scientific, clinical and marketing backgrounds with experience across many specialties in the rare disease space.
Our staff has an average of 20 years of experience and a proven ability to develop and foster long-lasting relationships with our clients as well as and influential opinion leaders. Our goal is to foster lasting partnerships with our clients that span the product’s lifecycle
Publication Planning
Posters, Abstracts, & Manuscript Development
Competitive Market Analysis
Regulatory Support
Live Case Presentations
Dinner Meetings
Symposia
Expert Commentary
KOL Mapping
Speakers Bureau Management
Advisory Board Development & Management
Exhibitor Booth Design & Management
KOL Development
Managing Partner
CinryzE
Fabrazyme
Prolastin C
Colcrys
Dificid
Aldurazyme
Chenodal
Cerezyme
Chiasma
Soliris
Vecamyl
Wilson Therapeutics
Spinraza
Thiola
